PMCF survey for a universal composite
A global dental manufacturer engaged us to run a post-market clinical follow-up survey among general practice dentists in the US and Russia, capturing clinician-reported evidence on the safety, restoration performance, and esthetics of its shade-matching universal composite.
- PMCF Survey
The brief
- Generate clinician-reported evidence on real-world performance and safety for post-market surveillance.
- Quantify post-operative sensitivity, fractures, marginal and surface staining, and luster issues.
- Capture satisfaction with radiopacity, colour matching, shade range, and esthetic outcomes.
- Identify any residual risks or unforeseen issues and deliver a dataset ready to feed the PMCF report.
The problem
No current clinician-reported evidence on real-world safety, restoration durability, and shade-matching performance for post-market surveillance
Our approach
A structured PMCF survey of 150 general practice dentists across the US and Russia, run under MRS code of conduct
- Designed a screened questionnaire covering usage history, safety, restoration performance, and esthetics.
- Fielded online to 150 licensed general practice dentists across the US and Russia.
- Screened on licensing, job role, competitor brand usage, and anterior and posterior case volumes.
- Built in an adverse-event and complaint reporting route, with confidentiality safeguards throughout.
Key outcomes
A clean, analysis-ready dataset covering safety, restoration performance, esthetics, and shade range, with adverse-event flagging
- Captured 150 QC'd responses across two markets, spanning anterior, posterior, repair, and core build-up use.
- Quantified agreement on radiopacity, adverse reactions, sensitivity, fractures, staining, luster, and colour matching.
- Measured complication rates and captured clinician feedback on the shade range available.
- Delivered a cleaned, coded raw data file ready for PMCF reporting and trend analysis.
Related services
Facing a similar challenge?
Tell us what decision you're facing. We'll turn it into a clear, evidence-backed answer.
